Literature DB >> 34454845

Impact of guideline-recommended dietitian assessments on weight gain in infants with cystic fibrosis.

Thida Ong1, Frankline M Onchiri2, Maria T Britto3, Sonya L Heltshe4, Larry G Kessler5, Michael Seid6, Bonnie W Ramsey4.   

Abstract

BACKGROUND: Cystic fibrosis (CF)-specialized nutrition care strives to meet normal infant growth, but the relationship of dietitian assessments to weight outcomes is unknown. We characterize nutrition management for inadequate weight gain and assess association of dietitian assessments and center-level weight-for-age Z-scores (WAZ).
METHODS: We used encounter data from 226 infants across 28 US CF Centers from the Baby Observational Nutritional study between January 2012 through December 2017. We identified dietitian assessments and consensus guideline-recommended responses to inadequate weight gain: calorie increases, pancreatic enzyme replacement therapy (PERT) increases, or shortened time to next visit. We compared center assessments by funnel plot and summarize median WAZ by center.
RESULTS: Of 2,527 visits, 808 (32%) visits had identified inadequate weight gain, distributed in 216 infants. Assessments occurred in 1953 visits (77%), but varied widely between centers (range 17% - 98%). For inadequate weight gain, most and least common responses were calorie increase (64%) and PERT increase (21%). Funnel plot analysis identified 4 high-performers for frequent dietitian assessments (range 92% - 98%) and 4 under-performers (range 17% - 56%). High-performers treated inadequate weight gain more often with adequate calories (24/30, 80% v. 12/23, 52%) and closer follow up (104/164, 63% v. 60/120, 49%) compared to under-performers. Three of 4 high-performing sites met center nutrition goals for positive median WAZ at 2 years old unlike 3 under-performers (WAZHigh 0.33 v. WAZLow -0.15), despite similar patient characteristics.
CONCLUSION: We characterized multicenter variation in dietitian assessments, identifying opportunities to improve care delivery to target early nutrition outcomes.
Copyright © 2021. Published by Elsevier B.V.

Entities:  

Keywords:  Guideline adherence; Medical nutrition therapy; Newborn; Patient registry; Pediatric; Weight surveillance

Mesh:

Year:  2021        PMID: 34454845      PMCID: PMC8844148          DOI: 10.1016/j.jcf.2021.08.005

Source DB:  PubMed          Journal:  J Cyst Fibros        ISSN: 1569-1993            Impact factor:   5.482


  31 in total

1.  Funnel plots for comparing institutional performance.

Authors:  David J Spiegelhalter
Journal:  Stat Med       Date:  2005-04-30       Impact factor: 2.373

Review 2.  Highlights from the nutrition guidelines for cystic fibrosis in Australia and New Zealand.

Authors:  Natalie van der Haak; Susannah J King; Tory Crowder; Andrea Kench; Catherine Painter; Nicole Saxby
Journal:  J Cyst Fibros       Date:  2019-06-04       Impact factor: 5.482

3.  Pancreatic Enzyme Replacement Therapy Use in Infants With Cystic Fibrosis Diagnosed by Newborn Screening.

Authors:  Daniel Gelfond; Sonya L Heltshe; Michelle Skalland; James E Heubi; Margaret Kloster; Daniel H Leung; Bonnie W Ramsey; Drucy Borowitz
Journal:  J Pediatr Gastroenterol Nutr       Date:  2018-04       Impact factor: 2.839

4.  Use of a learning network to improve variation in interstage weight gain after the Norwood operation.

Authors:  Jeffrey B Anderson; Robert H Beekman; John D Kugler; Geoffrey L Rosenthal; Kathy J Jenkins; Thomas S Klitzner; Gerard R Martin; Steven R Neish; Lynn Darbie; Eileen King; Carole Lannon
Journal:  Congenit Heart Dis       Date:  2014-10-31       Impact factor: 2.007

5.  Highlights from the 2018 North American cystic fibrosis conference.

Authors:  Stacey L Martiniano; Cori L Daines; Elisabeth P Dellon; Charles R Esther; Marianne S Muhlebach; Thida Ong; Elliot C Rabinowitz; Demet Toprak; Edith T Zemanick
Journal:  Pediatr Pulmonol       Date:  2019-05-15

6.  ESPEN-ESPGHAN-ECFS guidelines on nutrition care for infants, children, and adults with cystic fibrosis.

Authors:  Dominique Turck; Christian P Braegger; Carla Colombo; Dimitri Declercq; Alison Morton; Ruzha Pancheva; Eddy Robberecht; Martin Stern; Birgitta Strandvik; Sue Wolfe; Stephane M Schneider; Michael Wilschanski
Journal:  Clin Nutr       Date:  2016-03-15       Impact factor: 7.324

7.  Early Life Growth Trajectories in Cystic Fibrosis are Associated with Pulmonary Function at Age 6 Years.

Authors:  Don B Sanders; Aliza Fink; Nicole Mayer-Hamblett; Michael S Schechter; Gregory S Sawicki; Margaret Rosenfeld; Patrick A Flume; Wayne J Morgan
Journal:  J Pediatr       Date:  2015-09-02       Impact factor: 4.406

8.  The Cystic Fibrosis Foundation Patient Registry. Design and Methods of a National Observational Disease Registry.

Authors:  Emily A Knapp; Aliza K Fink; Christopher H Goss; Ase Sewall; Josh Ostrenga; Christopher Dowd; Alexander Elbert; Kristofer M Petren; Bruce C Marshall
Journal:  Ann Am Thorac Soc       Date:  2016-07

9.  Favorable Clinician Acceptability of Telehealth as Part of the Cystic Fibrosis Care Model during the COVID-19 Pandemic.

Authors:  Ryan C Perkins; Jaclyn Davis; Andrew NeSmith; Julianna Bailey; Michael R Powers; Nauman Chaudary; Christopher Siracusa; Ahmet Uluer; George M Solomon; Gregory S Sawicki
Journal:  Ann Am Thorac Soc       Date:  2021-02-26

Review 10.  Evidence-based practice recommendations for nutrition-related management of children and adults with cystic fibrosis and pancreatic insufficiency: results of a systematic review.

Authors:  Virginia A Stallings; Lori J Stark; Karen A Robinson; Andrew P Feranchak; Hebe Quinton
Journal:  J Am Diet Assoc       Date:  2008-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.